APVV-0084-07

Nadexpresia P-glykoproteínu a s ňou spojené zmeny v spektre a v hladinách bunkových oligo- a polysacharidov
Vedúca projektu: Ing. Zdena Sulová, DrSc.
Trvanie projektu: jún 2008 – december 2010
Publikácie: Sulova Z, Brtko J, Macejová D, Breier A: Are Nuclear Receptors for Retinoids Involved in the Control of the Expression and Activity of P-Glycoprotein? In Retinoic Acid: Structure, Mechanisms and Roles in Disease (Cheng, L.H., It, Y. eds.) NOVA Publisher, 2012 pp. 29-52.
Breier A, Gibalova L, Seres M, Barancik M, Sulova Z: P-glycoprotein mediated multidrug resistance of cancer tissue: Implication for cancer chemotherapy. ISBN 978-80-89233-55-7, PETRUS Publisher, 2012.
Breier A, Gibalova L, Seres M, Barancik M, Sulova Z. New insight into p-glycoprotein as a drug target. Anti-cancer Agents Med Chem. 13 (2013) 159-70. (IF2012=2.610).
Barancik M, Bohacova V, Gibalova L, Sedlak J, Sulova Z, Breier A. Potentiation of Anticancer Drugs: Effects of Pentoxifylline on Neoplastic Cells. Int. J. Mol. Sci. 13 (2012) 369-382.
Bubencíkova T, Cholujová D, Messingerová L, Mislovicova D, Seres M, Breier A, Sulova Z. Detection of glycomic alterations induced by overexpression of p-glycoprotein on the surfaces of l1210 cells using sialic Acid binding lectins. Int J Mol Sci. 13, (2012) 15177-15192.
Gibalová L, Sereš M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Toxicol In Vitro. 26 (2012) 435-444. (IF2012=2.650).
Šereš M, Cholujová D, Bubenčíkova T, Breier A, Sulová Z. Tunicamycin depresses p-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in l1210 cells. Int J Mol Sci. 12 (2011) 7772-7784. (IF2012=2.464).